We are proud to announce that Vaxinano has been selected as a winner of the INOV State Innovation Competition and is among the projects supported under #France2030!
A huge thank you to the French Government, ADEME, and Bpifrance for their trust and support through this ambitious initiative.Our SAVANT project (Advanced Accessible Thermostable Nasal Vaccine Solution) aims to industrialize our platform for the development of adjuvant-free, thermostable, and affordable nasal vaccines—a technology already validated in animal health and now being extended to human applications.
This recognition marks an important milestone in Vaxinano’s journey and further strengthens our commitment to delivering innovative solutions for the next generation of vaccines. 🚀
I would like to sincerely thank our entire R&D team, whose dedication over many years has made this achievement possible, with special thanks to @AngeloSCUOTTO and @RomainMagnez.
#France2030 #Innovation #Startup #Vaccines #NasalVaccines